Search

The purpose of this risk assessment is to evaluate the risk to the citizens of Europe of CPE spread through patient mobility and to assess the effectiveness of infection control methods to stop the spread of CPE within healthcare institutions.

This report presents antimicrobial resistance data reported to EARS-Net by 28 countries for 2010 with trend analyses for the period 2007-2010. This edition also includes a focus chapter on carbapenem-resistant K. pneumoniae and P. aeruginosa.

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010.

This response plan is designed to prevent the spread of multidrug-resistant Neisseria gonorrhoeae (MDR NG) in the EU/EEA in the context of the possible emergence of untreatable gonorrhoea

In 2011, a pilot study was undertaken to assess the public health benefit of molecular surveillance for gonorrhoea in 21 EU/EEA countries. A total of 1 066 isolates collected under the 2010 European gonococcal antimicrobial surveillance programme were typed and 406 sequence types identified, with considerable diversity among countries.

This report presents antimicrobial resistance data for seven invasive pathogens of major public health importance: Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae and Pseudomonas aeruginosa.

The antimicrobial resistance data among zoonotic and indicator bacteria in 2011, submitted by 26 EU Member States, were jointly analysed by the EFSA and ECDC.

In recent years, triazole resistance in human Aspergillus diseases appears to have been increasing in several European countries. However, current data on the prevalence of resistance are based on a small number of studies which are only available from a few European countries. A thorough investigation of this emerging public health problem is needed to avoid the development and spread of resistance.